Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Napier

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Hippocampus|September 13, 2024
P2X7 expression patterns in the developing Fmr1-knockout mouse hippocampusMatthew Napier, Ashish Kumar, Natasha Szulist, et al.
Neuromolecular Medicine|September 10, 2024
Dysregulated Purinergic Signalling in Fragile X Syndrome Cortical AstrocytesKathryn E Reynolds, Matthew Napier, Fan Fei, et al.
Expert Review of Vaccines|July 20, 2025
The broader socio-economic value of adult respiratory disease vaccinations in the UK - results from a benefit cost analysisCale Harrison, Simon Brassel, Sulayman Chowdhury, et al.
Expert Review of Vaccines|July 20, 2025
A benefit-cost analysis quantifying the broader socioeconomic value of adult respiratory vaccination programs in JapanClaud Theakston, Matthew Napier, Simon Brassel, et al.
Expert Review of Vaccines|July 1, 2026
Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit-cost analysisMatthew Napier, Alejandra López-Ibánez de Aldecoa, Simon Brassel, et al.
Expert Review of Vaccines|July 1, 2026
Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit-cost analysisEllie Tunnicliffe, Matthew Napier, Claud Theakston, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Hippocampus|September 13, 2024
P2X7 expression patterns in the developing Fmr1-knockout mouse hippocampusMatthew Napier, Ashish Kumar, Natasha Szulist, et al.
Neuromolecular Medicine|September 10, 2024
Dysregulated Purinergic Signalling in Fragile X Syndrome Cortical AstrocytesKathryn E Reynolds, Matthew Napier, Fan Fei, et al.
Expert Review of Vaccines|July 20, 2025
The broader socio-economic value of adult respiratory disease vaccinations in the UK - results from a benefit cost analysisCale Harrison, Simon Brassel, Sulayman Chowdhury, et al.
Expert Review of Vaccines|July 20, 2025
A benefit-cost analysis quantifying the broader socioeconomic value of adult respiratory vaccination programs in JapanClaud Theakston, Matthew Napier, Simon Brassel, et al.
Expert Review of Vaccines|July 1, 2026
Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit-cost analysisMatthew Napier, Alejandra López-Ibánez de Aldecoa, Simon Brassel, et al.
Expert Review of Vaccines|July 1, 2026
Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit-cost analysisEllie Tunnicliffe, Matthew Napier, Claud Theakston, et al.
Pageof 1